Clinical trial
Magnetic Resonance (MR) Spectroscopy of Breast Cancer Tissue
NCT00184210 · Norwegian University of Science and Technology, Other · Terminated
Key facts
| NCT number | NCT00184210 |
|---|---|
| Title | Magnetic Resonance (MR) Spectroscopy of Breast Cancer Tissue |
| Official title | HR MAS MR Spectroscopy of Breast Cancer Tissue |
| Lead sponsor | Norwegian University of Science and Technology, Other |
| Collaborators | The Research Council of Norway The Norwegian Women´s Public Health Association |
| Status | Terminated |
| Study type | Observational |
| Conditions | Breast Neoplasms |
| Enrollment | 1,000 |
| Start date | Jan 1, 2000 |
| Primary completion | Dec 1, 2020 |
| Completion | Dec 1, 2020 |
| First posted | Sep 16, 2005 |
| Last update posted | Mar 22, 2021 |
| Countries | Norway |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: